ETF Building Blocks Channel Biotech ETF Doesn’t Need Coronavirus Vaccines to Soar By Tom LydonJune 2, 2020
Beyond Basic Beta Channel Biotech Benefits as Companies Race to Cure Coronavirus By Tom LydonMay 26, 2020
Featured Biotech ETFs Stable Despite Disappointing Treatment Date From Gilead By Ian YoungApril 23, 2020
Beyond Basic Beta Channel Biotech ETFs Brush Off Political Attacks on Drug Prices By Tom LydonJanuary 21, 2020
Innovative ETFs Channel Biotech ETFs Strengthen as Amgen Invests in China’s BeiGene By Max ChenNovember 1, 2019
Beyond Basic Beta Channel Biotech ETFs Could Use Some Mergers & Acquisitions By Tom LydonMay 17, 2019
Equity ETFs Biotech ETFs Rally as Pence Promises ‘Orderly Transition’ Away from Obamacare By Max ChenJanuary 4, 2017